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Cytochrome P450 IA2, a liver-specific member of the 3-methylcholanthrene-inducible family, is never detected in established cell lines. With the 
aim of isolating cells stably producing this protein, we have used rat and mouse hepatoma cells as recipients in transfection experiments involving 
rabbit cytochrome P450 IA2 cDNA. We report here the isolation of five hepatoma cell clones expressing functional P450 IA2. The level of expression 
is comparable to that found in COS celis transiently transformed by other P450 cDNAs. It ranges between 0.4 and 1.6 pmol P450 IAZ/mg total 
cell protein. 
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1. I~RODUCTION 
Cytochromes P450 constitute a large family of hemo- 
proteins expressed mainly in hepatocytes. They are in- 
volved in the metabolism of endoge~ous ubstrates and 
in the first step (Phase I) of the detoxication pathway of 
xenobiotics [I]. Toxicological studies involving cyto- 
chrome P450 would profit from the availability of 
mamm~ian cell lines of hepatic origin showing stable 
expression of one or more P450 enzymes. Such lines 
should retain activity of the Phase II conjugating en- 
zymes necessary for the final steps of drug metabolism 
[2]. Rat and mouse hepatoma cells have been shown to 
express the P4SO IA1 isoenzyme of the MC-inducible 
family [3,4]. While hepatoma cell lines show promise as 
in vitro models for toxicology, their usefulness would 
be greatly enhanced by increasing the spectrum of the 
cytochromes P450 that are expressed. 
The second member of the MC-inducible family, 
cytochrome P450 IA2, is first expressed in rat and 
mouse liver near birth [5,6]. This enzyme is always ab- 
sent in hepatomas, and in all liver derived permanent 
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lines, ~though it may be maintained in short-term non- 
proliferating hepatocytes [7]. Several cDNAs encoding 
this isoenzyme have been cloned recently [8,9] and suc- 
cessfully expressed in heterologous yeast expression 
systems [9, lo]. 
Our goal is to transfer a P450 IA2 encoding cDNA in- 
to rat and mouse hepatoma cells that already express 
P450 IA1 in order to generate cell lines showing expres- 
sion of both members of the Mu-inducible P450 family 
of enzymes. Therefore, we have transfected these cells 
with rabbit cytochrome P450 IA2 cDNA [9] in vectors 
where expression is directed by either the strong SV40 
early promoter, or the weaker but inducible MMTV 
promoter. 
2. MATERIALS AND METHODS 
2.1. Cell lines and cell culture conditions 
H4II rat and BTG9 mouse hepatoma cells have been previously 
described [ 11,121. BTG9 cells carry a thioguanine resistance marker 
and are thus unable to grow in HAT medium unless a functional 
HPRT or Eco-gpt enzyme is introduced. Both cell lines were 
cultivated in modified Ham’s_Fit medium as described [13]. Trans- 
fection experiments were carried out according to [12]. For neo selec- 
tions, G418 (Gibco) was added to the culture medium at a final con- 
centration of 6OOc(g per ml. For DEX inductions, the cells were 
treated with 2 x 10e6 M DEX for 48 h from the day after transfec- 
tion. 
2.2. Plasmid vectors 
The P450 expression plasmids were constructed by inserting the 
(5’)BumHI-EcoRI(3’) restriction fragment of pA703/VGAL [9], 
coding for rabbit P450 IA2, downstream of either the SV40 or the 
MMTV promoter (fig.1). The P450 IA2 cDNA fragment does not 
contain any 5’ or 3’ non-coding sequences. The remainder of the 
00145793/89/%3.50 0 1989 Federation of European Biochemical Societies 175 
Volume 259, number 1 FEBSLETTERS December 1989 
Promoter Coding sequence Poly A I t splice 
(SV40) 
1 1551 __ 
early SV40 1 ACATG P450 IA2 cDNA 7~4 1 
___ 
--p 
___ 
HI8 WE9 E 
. I 
_’ 
I 
-H 
MMTVLTR [-- 
SIlli- 
Fig. 1. Structure of rabbit cytochrome P450 IA2 expression cassettes. Correspondence for the unique restriction sites indicated is as follows: B, 
BumHI; Bg, &/II; H, HindIII; E, EcoRI; Pv, PvuII; Sm, SmaI. Numbers indicate the positions of the first (1) and last (1551) nucleotide of the 
P450 IA2 coding sequence. 
structure of the P450 expression plasmids is that of pSV2 [14]. 
pSVIA2 and pMMTVIA2 are 5710 and 6935 base pairs long, respec- 
tively. 
The pSVgpt plasmid has been described previously [15]. The 
pSVneo plasmid was a gift from P. Herbomel. 
2.3. Enzyme assays and P450 contents 
The names used for the P45Os studied here respect he new recom- 
mended nomenclature (see [16]). The P450 IA1 content was deduced 
from its NADPH-dependent 7-EOR 0-deethylase activity using 
published procedures [8] and a turnover number of 3 pmol resorufin 
formed per pmol of mouse P450 IA1 and per min. The substrate con- 
centration was 2.5 FM and activities were corrected as appropriate for 
the contribution of P450 IA2 (EOR 0-deethylase, turnover number: 
0.03 mini). The P450 IA2 content was deduced from the CHP- 
dependent 7-EOC O-deethylase activity [9]. Using 660 PM CHP and 
IOOpM EOC, a turnover number of 0.1 min-’ was observed for 
purified or microsome bound P450 IA2 [9]. 
2.4. Nucleic acid analysis 
DNA and RNA preparations, Northern and Southern blots have 
been carried out following standard procedures [17]. Northern and 
Southern blot hybridization and washes were performed as described 
[18]. Autoradiography was performed using DuPont Quanta III in 
tensifying screens. 
3. RESULTS AND DISCUSSION 
3.1. P450 contents 
Measurements of P450 activities making it possible to 
distinguish unambiguously between P450 IA1 (endo- 
genous) and IA2 (introduced) activities were carried out 
as described [9, lo]. The rationale for the calculation is 
the following. Although substrate specificities of rat or 
mouse P450 IA1 and rabbit P450 IA2 show partial 
overlap, the choice of a particular set of tests allowed 
calculation of the respective P450 IA1 and IA2 
amounts. P450 IA1 content was deduced from 
NADPH-dependent 7-EOR 0-deethylase activity for 
which the IA2 contribution is only 1% at an identical 
enzyme concentration. The P450 IA2 determination 
resulted from measurement of a CHP-dependent 
7-EOC 0-deethylase activity for which the IA1 inter- 
ference is low and decreases rapidly with time due to 
selective inactivation of P450 IA1 by hydroperoxides. 
The P450 IA1 and IA2 contents were deduced from the 
values of these two assays assuming specific activities 
given in section 2. Thus, the calculated P450 amount 
corresponds only to the amound of catalytically compe- 
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tent enzyme. All the results presented here will thus 
refer to P450 contents instead of activities. 
3.2. Transfection and selection to obtain cell clones 
showing stable expression of P450 IA2 
Two hepatoma cell lines, HUI (rat) and BTG9 
(mouse) that differ in their expression of cytochromes 
P450 and of fetal and neonatal hepatic functions (table 
1) were chosen for this work. The P450 expression plas- 
mids were constructed as specified in section 2, and 
their main features are shown in fig.1. That both plas- 
mids encode functional P450 IA2 was demonstrated by 
transitory expression experiments with the two cell lines 
(data not shown). With the MMTV promoter no en- 
zyme at all is present in uninduced cells, indicating a 
basal expression more than 15 times lower than that of 
the SV promoter. Using the induction conditions that 
we have determined to be optimal (2 x 10m6 M DEX for 
48 h from the day after transfection), expression cor- 
responding to at least one third of that from the SV pro- 
moter is obtained. 
3.2.1. Isolation of pools of transfected colonies 
Two plasmids, pSVgpt and pSVneo carrying respec- 
tively the Eco-gpt and neoselective markers were 
employed in cotransfection experiments with P450 IA2 
plasmids. 
H411 and BTG9 cells cotransfected with pSVneo and 
pSVIA2 gave rise to colonies growing in the presence of 
G418 after 2-4 weeks. These colonies were pooled and 
analyzed for P450 IA2 expression (fig.2). The mRNA 
level was weak for H411 cells, for which the signal inten- 
Table 1 
Characteristics of recipient cells 
H4II BTG9 
Cytochrom P450 IAI, IIB1/2, IIC6 IA1 
Phase II enzymes + + 
Neonatal enzymes + - 
Albumin + + 
Alphafoetoprotein _ + 
Phenotypic properties of H411 rat and BTG9 mouse hepatoma cells. 
Cytochrome P450 names are according to the new nomenclature 
[16]. + and - represent semi-quantitative estimates based on Nor- 
thern blots and/or protein contents [11,21] and unpublished results 
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Fig.2. Expression of P450 IA2 mRNA and enzyme in pools of 
total cell protein. 
pSVIA2 transfected hepatoma cells during selection. (A) Northern 
blot analysis of total cellular RNA in pools of transfected H4II or 
BTG9 clones, probed with the rabbit cytochrome P4SO IA2 cDNA. 
15 pg total RNA from pools after two weeks (a) or five weeks (b) of 
selection. The longer time corresponds to the isolation of individual 
clones (30 cell generations). (B) Cytochrome P450 IA2 content was 
calculated from 7-EOC 0-deethylase activity measurements ( ee sec- 
tion 2). Values are expressed in pmol cytochrome P450 IA2 per mg of 
sity was clearly not proportional to the enzyme content 
measured. When examined at 5 weeks, the mRNA level 
was below the limit of detection but the enzyme level re- 
mained almost unchanged. For BTG9 cells, both the 
mRNA signal and enzyme content became undetectable 
after 5 weeks, indicating for these cells a clear tendency 
toward loss of P450 IA2 expression. To investigate the 
nature of this apparent instability, two experiments 
were carried out: determination of the frequency of col- 
ony formation with different combinations of plas- 
mids, and study of the evolution of individual clones of 
transfected cells. 
3.2.2. Isolation of individual clones 
Table 2 shows the frequency of colony formation 
under selective conditions. H4II cells transfected with 
pSVneo alone or in combination with either one of the 
P450 expression vectors gave the same frequency of 
G418 resistant colonies, of generally healthy ap- 
pearance. In all cases, the transfection efficiency of 
H411 cells is lower than that observed for BTG9 cells. 
The mouse BTG9 hepatoma cells, when transfected 
with pSVneo or pSVgpt alone, or in combination with 
pMMTVIA2 give rise to colonies at high frequency. 
However, when the pSVIA2 plasmid is introduced, the 
number of colonies is dramatically decreased, by a fac- 
tor of 10-100. In addition, examination of the dishes 
revealed that BTG9 colonies developed normally in all 
sets of dishes that did not involve pSVIA2. When the 
P450 expression vector included the SV promoter, the 
BTG9 colonies failed to grow vigorously, and were 
composed of vacuolated unhealthy cells; many colonies 
died altogether. This phase of ‘crisis’ lasted for lo-20 
generations, at which time the cells recovered, or were 
lost. These observations uggest that high level expres- 
sion of the P450 IA2 protein impairs the growth of most 
of the BTG9 cells. In view of the striking behaviour of 
BTG9 cells transfected with pSVIA2, a large number of 
clones were isolated and characterized. From the other 
transfection series of the two hepatoma lines, at least 5 
colonies were picked and expanded. 
3.3. Analysis of isolated hepatoma cell clones 
The DNA extracted from BTG9 clones selected after 
transfection in the presence of pSVgpt was digested by 
EcoRI, blotted onto filters and hybridized with the 
P450 IA2 insert (fig.3). This enzyme cuts once in the 
two P450 expression vectors outside of the P450 IA2 
coding sequence. A very different pattern of plasmid in- 
corporation was observed depending upon the pro- 
moter driving P450 IA2 expression. The MMTVIA2 
clones all carry a large number of tandem-integrated in- 
tact plasmids (more than 50 copies). Among clones 
transfected with pSVIA2, only 5 out of 9 contain at 
least one intact plasmid copy per cell; the others carry 
either no hybridizing material or smaller fragments. We 
have obtained similar results in the case of the cotrans- 
fection experiment involving both pSVneo and pSVIA2 
plasmids (data not shown), No change in the patterns of 
plasmid integration was observed after prolonged 
culture (data not shown). The fact that only about half 
of the pSVIA2 transfected clones retain intact copies of 
the plasmid may be due to a negative selection over 
P450 IA2 expressing cells during clone isolation. In ad- 
dition, it is striking that massive incorporation of plas- 
mid copies occurs only when IA2 expression is driven by 
a weak promoter. 
H411 cells demonstrated a pattern of plasmid integra- 
tion similar to that for BTG9: large numbers of tandem- 
Table 2 
Frequencies of neoR or HATR colonies after co-transfection 
Selection plasmid pSVne0 PSVgPt 
P450 expression None pSVIA2 pMMTVIA2 None pSVIA2 PMMTVIAZ 
plasmid 
Cells H4II 1 2 (5) 1.7 (5) _ 
BTGP 100 10 (9) - 30 0.5 (9) 80 (6) 
Frequencies are expressed as transfectants per l@ cells; - , not determined; in parentheses, number 
of clones isolated 
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Fig.3. Cytochrome P450 IA2 cDNA sequences in individual clones of BTG9 transfected cells. Southern blot analysis of BTG9 transfected clones. 
Genomic DNA (11 yg) from each cell clone were digested with EcoRI, electrophoresed through a 0.8% agarose gel, transferred to nylon N-Hybond 
membranes and probed with P450 IA2 cDNA. (a) Endogenous P450 IA2 mouse gene; (b) Integrated copies of P450 IA2 containing plasmids. 
Numbers at the bottom refer to cell clones showing expression of the rabbit P450 IA2 enzyme. 
integrated intact copies for MMTVIA2, and fewer than 
five copies, showing variable integration sites, for 
SVIA2 (see below). 
Cytochrome P450 IA2 expression was assayed in 
each of the isolated H411 or BTG9 clones. Table 3 sum- 
marizes the results obtained soon after clone isolation 
(early) or after more than 50 cell generations (late). In 
H411 cells, the SVIA2 vector was expressed in most 
clones, and good P450 IA2 expression retained for two 
of them. Detectable xpression of the MMTV construct 
was rare, and the single clone that maintained P450 IA2 
expression showed an enzyme level close to the limit of 
detection. 
Among the BTG9 clones transfected with the SVIA2 
vector, only 3 out of 8 (HAT plus G418 selections) 
which contain at least one intact copy of the pSVIA2 
plasmid actually produce the enzyme. Two of these 
clones proved to be stable upon long term culture. In 
addition, the BTG9 clones transfected with MMTVIA2 
fail to express P450 IA2 upon long term cultivation. For 
comparison, the P450 IA1 contents of pools of 
transfectants from both H411 and BTG9 cells are 
shown. 
Fig.4 presents the profile of plasmid incorporation, 
of P450 IA2 transcripts, and of P450 IA2 enzyme con- 
tent for each of the five transfected clones that show 
stable expression of the introduced P450 IA2. It will be 
noted for one of the H411 clones that a weak mRNA 
signal may be associated with significant enzyme con- 
tent, as noted above (fig.2) for pooled clones. The 
absence of correlation between the P450 IA2 mRNA 
and enzyme contents in these cells suggests that there is 
a limitation in activity of the rabbit enzyme, due for ex- 
ample to a reduced coupling efficiency between the rat 
Table 3 
Characterization of P450 IA2 expressing clones 
P450 IA2 
pSVIA2 pMMTVIA2*** P450 1Alj.t 
early* late** early late 
number of positive 4 (5) 2 (5) 1 (5) 1 (5) 
H411 P450 content? 0.6-2.2 0.6-0.8 0.4 0.4 0.45 
number of positive 3 (18) 2 (18) 2 (6) 0 (6) 
BTG9 P450 content 1.6-2.0 1.6-1.8 1.5-1.6 <0.3 10 
The number of positive clones and their corresponding ranges of P450 IA2 content are in- 
dicated; t, pmol P450 IA2 per mg of total cell protein, range among expressing clones; *, 30 
cell generations after transfection; **, >50 cell generations after transfection; ***, dex- 
amethasone induction, 2 x 10e6 M for 48 h from the day after transfection; tt, P450 IA1 
expression (pmol per mg of total cell protein) from the endogenous gene in pools of transfec- 
tants; in parentheses, total number of isolated clones tested for P450 IA2 content 
178 
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Fig.4. Characteristics of P450 IA2 expressing clones. For each clone, 
integrated plasmid copies, mRNA level and protein content are 
shown. (A) Southern blot analysis of genomic DNA from H4II and 
BTG9 cell clones digested with BumHl or EcoRl, respectively, prob- 
ed with P450 IA2 cDNA. The arrows show the position of intact in- 
tegrated plasmids. (B) Northern blot of RNA from the same clones. 
For the H411 clones transfected by pMMTVIA2, the mRNA level cor- 
responds to DEX-treated cells (2 x 1Om6 M for 48 h from the day 
after transfection). (C) P450 IA2 enzyme level (see legend of fig.2). 
(endogenous) NADPH-P450 reductase and the rabbit 
(introduced) P450 form. For individual as well as pool- 
ed clones of BTG9, a strong RNA signal is correlated 
with generally higher enzyme content. The fact that two 
mRNA bands are found for both vectors and in both 
H411 and BTG9 cells may be due to an alternative splic- 
ing of the SV40 intron present downstream of the TGA 
termination codon of the P450 IA2 cDNA. The stably 
expressing clones produce significant P450 IA2 enzyme, 
giving values ranging from 0.4 to 1.6 pmol P450 
IA2/mg total cell protein. 
4. CONCLUSIONS 
Two lines of evidence presented here indicate that 
production of large amounts of the P450 IA2 enzyme is 
not compatible with cell growth for the majority of 
BTG9 cells. A phenomenon of negative selection for 
such cells is indicated by the drastic reduction in the fre- 
quency and the vigor of clones surviving selection when 
the transfection involved pSVIA2. The second argu- 
ment comes from the observation of loss of P450 IA2 
protein upon prolonged culture both from pooled col- 
onies and from the majority of isolated clones. In some 
cases however, the apparent oxicity of the enzyme can 
be overcome, since clones that show stable expression 
of the introduced plasmid were obtained. H411 cells did 
not seem to be affected by the presence of the enzyme, 
and clones showing stable expression of the plasmid 
vector were isolated at a reasonable frequency. 
A difference in behaviour of the two hepatoma lines 
may not be surprising: H411 cells express a large number 
of hepatic functions restricted to postnatal hepatocytes, 
the stage when the P450 IA2 gene is first expressed, 
while BTG9 cells do not. It can be suggested that P450 
IA2 enzyme interferes with the metabolism of en- 
dogenous substrates, possibly steroid compounds, 
when produced in a metabolic context devoid of other 
postnatal hepatic functions. 
We report here the first example of the establishment 
of liver cell lines stably expressing rabbit P450 IA2. The 
enzyme level is about 100 times lower than that obtain- 
ed in mammalian cells infected by vaccinia viruses that 
permit transient expression of other P450 activities, or 
in stably transformed yeast cells [9,19]. However, the 
enzyme levels we have observed are comparable to 
those found in COS cells transfected with other P450 
cDNAs in expression vectors [20], and they range be- 
tween 2.5 x lo4 and 10 x 104 P450 IA2 molecules per 
cell. 
The methodology we used can be applied to other 
xenobiotic-metabolizing enzymes. Hepatoma cells 
showing stable expression of a large spectrum of both 
Phase I and Phase II detoxication enzymes hould be of 
great value in toxicology. 
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